Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes

The two generic drugs have been launched under the brand names Jankey & Sitenali.

Thyrocare Technologies posts Q1FY23 consolidated PAT at Rs. 21.73 Cr

The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.

Health Minister Mandaviya addresses inaugural ceremony of training programme for senior administrative medical officers of CGHS

Health resources – both human and material are precious assets to the society and a robust health care administration and management system ensures their effective utilization: Dr Bharati Pravin Pawar

Casper Pharma completed USFDA pre-approval inspection

The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.

Shilpa Medicare's Unit III, Advanced Analytical Characterization Laboratory clears US FDA remote record review

The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing

Cipla posts Q1FY23 consolidated PAT at Rs. 686.40 Cr

he company has reported total income of Rs. 5478.62 crores during the period ended June 30, 2022.

Torrent Pharmaceuticals posts Q1FY23 consolidated PAT Rs. 354 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.

Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma

GMM Pfaudler Q1FY23 consolidated PAT surges to Rs. 44.51 Cr

GMM Pfaudler has reported total income of Rs. 767.73 crores during the period ended June 30, 2022

Biocon Q1FY23 consolidated PAT falls QoQ at Rs. 144.4 Cr

Biocon has reported total income of Rs. 2217.4 crores during the period ended June 30, 2022.